David L. Fitzgerald

Array ( [id] => 3924444 [patent_doc_number] => 05945397 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-31 [patent_title] => 'Purified p75 (type II) tumor necrosis factor receptor polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/650000 [patent_app_country] => US [patent_app_date] => 1996-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 17776 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/945/05945397.pdf [firstpage_image] =>[orig_patent_app_number] => 650000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359927 [patent_doc_number] => 06169070 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'Mer receptor activation by gas6' [patent_app_type] => 1 [patent_app_number] => 8/628747 [patent_app_country] => US [patent_app_date] => 1996-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 27 [patent_no_of_words] => 28657 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/169/06169070.pdf [firstpage_image] =>[orig_patent_app_number] => 628747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3931734 [patent_doc_number] => 05939286 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-17 [patent_title] => 'Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them' [patent_app_type] => 1 [patent_app_number] => 8/631328 [patent_app_country] => US [patent_app_date] => 1996-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 40 [patent_no_of_words] => 44558 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/939/05939286.pdf [firstpage_image] =>[orig_patent_app_number] => 631328 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234532 [patent_doc_number] => 06080398 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Truncated gro and KC chemokines having enhanced bioactivity' [patent_app_type] => 1 [patent_app_number] => 8/557142 [patent_app_country] => US [patent_app_date] => 1996-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 17578 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080398.pdf [firstpage_image] =>[orig_patent_app_number] => 557142 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3828770 [patent_doc_number] => 05814314 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-29 [patent_title] => 'Non-glycosylated, recombinant human IL .sub.2 in reduced form' [patent_app_type] => 1 [patent_app_number] => 8/601434 [patent_app_country] => US [patent_app_date] => 1996-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 5882 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/814/05814314.pdf [firstpage_image] =>[orig_patent_app_number] => 601434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4137922 [patent_doc_number] => 06060271 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'CDNA fragments corresponding to voltage gated sodium channel genes expressed in peripheral nerve' [patent_app_type] => 1 [patent_app_number] => 8/605284 [patent_app_country] => US [patent_app_date] => 1996-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18545 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060271.pdf [firstpage_image] =>[orig_patent_app_number] => 605284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3938025 [patent_doc_number] => 05997860 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-07 [patent_title] => 'Ex-vivo expansion of stem cells using combinations of interleukin-3 (IL-3) variants and other cytokines' [patent_app_type] => 1 [patent_app_number] => 8/559009 [patent_app_country] => US [patent_app_date] => 1995-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 40337 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/997/05997860.pdf [firstpage_image] =>[orig_patent_app_number] => 559009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4229563 [patent_doc_number] => 06074639 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Ex vivo expansion of hematopoietic cells using interleukin-3 (IL-3) variant fusion proteins' [patent_app_type] => 1 [patent_app_number] => 8/559267 [patent_app_country] => US [patent_app_date] => 1995-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 41138 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 510 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/074/06074639.pdf [firstpage_image] =>[orig_patent_app_number] => 559267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3982044 [patent_doc_number] => 05861285 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-19 [patent_title] => 'Fusion protein-bound magnetic particles for recombinant production and magnetic separation of polypeptides of interest' [patent_app_type] => 1 [patent_app_number] => 8/529600 [patent_app_country] => US [patent_app_date] => 1995-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 6769 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/861/05861285.pdf [firstpage_image] =>[orig_patent_app_number] => 529600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4359897 [patent_doc_number] => 06169068 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-01-02 [patent_title] => 'Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives' [patent_app_type] => 1 [patent_app_number] => 8/602761 [patent_app_country] => US [patent_app_date] => 1995-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 25 [patent_no_of_words] => 17927 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/169/06169068.pdf [firstpage_image] =>[orig_patent_app_number] => 602761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4046662 [patent_doc_number] => 05912324 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Interferon-gamma (IFN-.gamma.) inducing factor (IGIF, IL-18) purified from murine liver' [patent_app_type] => 1 [patent_app_number] => 8/502535 [patent_app_country] => US [patent_app_date] => 1995-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 16217 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912324.pdf [firstpage_image] =>[orig_patent_app_number] => 502535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3868999 [patent_doc_number] => 05824300 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Treatment of neoplastic disease with oral interferon' [patent_app_type] => 1 [patent_app_number] => 8/479958 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7008 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824300.pdf [firstpage_image] =>[orig_patent_app_number] => 479958 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4087152 [patent_doc_number] => 06162896 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-19 [patent_title] => 'Recombinant vertebrate activin receptors' [patent_app_type] => 1 [patent_app_number] => 8/476123 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 17935 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 162 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/162/06162896.pdf [firstpage_image] =>[orig_patent_app_number] => 476123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3929376 [patent_doc_number] => 05877275 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Controlling cellular immune/inflammatory responses with .beta.2 integrins' [patent_app_type] => 1 [patent_app_number] => 8/476062 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 10 [patent_no_of_words] => 10251 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877275.pdf [firstpage_image] =>[orig_patent_app_number] => 476062 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770277 [patent_doc_number] => 05817307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Treatment of bacterial infection with oral interferon-.alpha.' [patent_app_type] => 1 [patent_app_number] => 8/484376 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6963 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817307.pdf [firstpage_image] =>[orig_patent_app_number] => 484376 [rel_patent_id] =>[rel_patent_doc_number] =>)